Le Lézard
Classified in: Health
Subjects: ASI, FEA

Apollo Hospitals, India becomes the first Asian Hospital to perform four consecutive MitraClip procedures in a day


CHENNAI, India, March 16, 2021 /PRNewswire/ -- The Apollo Hospitals group, one of Asia's largest and most trusted healthcare group, notched up a record milestone with the successful completion of four consecutive  MitraClip procedures in one day. The MitraClip implants were carried out on four patients suffering from severe heart failure on the same day. This record surpasses Japan, where MitraClip procedures were performed on three patients in a day.

Dr Sai Satish, Senior Interventional Cardiologist, Apollo Hospitals, Chennai performed the four procedures. The minimally invasive method used to implant the MitraClip allows repair of a leaking mitral valve without open-heart surgery, and is a lifesaver for patients at high surgical risk. All four patients, the oldest of whom was 87 years old, went home walking within 3 days and are currently doing well.

Dr Prathap C Reddy, Chairman, Apollo Hospitals Group said, "It is a matter of pride that Apollo Hospitals is among the select few hospitals in India accredited to perform the MitraClip procedure with our surgeons achieving a milestone that is a first in the Asian continent."

Ms. Suneeta Reddy, Managing Director, Apollo Hospitals Group said, "Keeping with our industry leading initiatives of bringing the best and latest in medical technology for the benefit of patients in India, we introduced MitraClip for the treatment of patients with mitral valve leaks, a condition that has very little avenue of treatment, especially for the elderly in their 80s."

Dr. Sai Satish, Senior Interventional Cardiologist, Apollo Hospitals said, "We have been performing MitraClip procedures for about three years now. It was the confidence gained through our extensive experience that enabled us to perform consecutive MitraClip implants in four very sick patients in just one day."

Dr. Sai Satish has consistently led in performing procedures on the mitral valve with the highest number of MitraClip implants in India, having performed over 60% of cases in India since its introduction in the country.

Apollo Hospitals is also developing the Echo Connect Project, to help patient with leaking mitral valves across the country with echocardiography conducted locally and referrals to the apex center at Apollo Chennai for the life-saving MitraClip procedure. Apollo Hospitals is at the forefront of making the MitraClip available, as it becomes the standard of care for patients with heart failure showing no improvement with medicines.

For more information, contact: [email protected]

 

SOURCE Apollo Hospitals


These press releases may also interest you

at 14:48
Expanding Innovationstm (EI), an emerging leader in expandable implant technology for spine surgery, is proud to announce its participation in the 2025 AANS/CNS Joint Section Spine Summit in Tampa, FL, from February 20-23. Attendees are invited to...

at 14:38
ZoaDx, a newly launched clinical research organization, is dedicated to advancing animal health and agricultural sustainability through expert clinical research, tailored regulatory solutions, and quality assurance consulting. With a focus on...

at 14:30
New subgroup data from the investigational Phase III ARANOTE trial show NUBEQA® (darolutamide) plus androgen-deprivation therapy (ADT) improved radiological progression-free survival (rPFS) in patients with high and low-volume metastatic hormone...

at 14:30
Olympus Partners has acquired PAI Pharma ("PAI"), the leading developer, manufacturer and distributor of generic oral liquids in both ready-to-dose cups and bottles in the United States. PAI offers the broadest portfolio of generic oral liquid...

at 14:26
Life Time , the nation's premier healthy lifestyle brand, is hosting its annual Ride of a Life Time charity indoor workout event at Life Time destinations nationwide on March 8. As it celebrates the fifth year of raising funds...

at 14:26
Aurora Pharmaceutical is pleased to announce the availability of EquiCoxib, the FDA-approved generic equivalent of Equioxx® (firocoxib), a non-steroidal anti-inflammatory drug (NSAID) used for pain and inflammation associated with osteoarthritis....



News published on and distributed by: